Clincosm LogoSign in Get a demo

chronic myelogenous leukemia

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib followed by treatment-free
  • Fort Myers, Florida
  • +113 more
Apr 25, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in United

    Completed
    Has Results
    • Acute Biphenotypic Leukemia
    • +4 more
    • Duarte, California
    • +7 more
    Jun 13, 2021

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • +3 more
    • Duarte, California
    • +100 more
    Jun 8, 2021

    Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

    Completed
    • Related Donors Donating PBSC to a Family Member
    • +7 more
    • Tampa, Florida
    • +11 more
    Sep 3, 2020

    Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

    Completed
    Has Results
    • Acute Leukemia
    • +8 more
    • Tacrolimus (ARM with Methotrexate)
    • +7 more
    • Duarte, California
    • +29 more
    Jan 2, 2019

    Chronic Myelogenous Leukemia Trial in Boston (Arsenic trioxide)

    Terminated
    • Chronic Myelogenous Leukemia
    • Arsenic trioxide
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Sep 4, 2018

    Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • imatinib mesilate
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Aug 7, 2013

    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

    Completed
    • Acute Lymphoblastic Leukemia
    • +5 more
    • VCL-CB01
    • Phosphate-buffered Saline (PBS)
    • Tucson, Arizona
    • +21 more
    Jul 31, 2013

    Acute Myelogenous Leukemia, GVHD, Acute Lymphoblastic Leukemia Trial in Boston (sirolimus, tacrolimus)

    Completed
    • Acute Myelogenous Leukemia
    • +6 more
    • Boston, Massachusetts
      Dana-Farber Cancer Center
    Jan 24, 2012

    Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • Birmingham, Alabama
    • +69 more
    Apr 13, 2011